zero-p implants packed with tricalcium phosphate or locally removed bone Search Results


90
Corning Life Sciences bone-mimicking calcium phosphate-coated osteo assay stripwell plates
Bone Mimicking Calcium Phosphate Coated Osteo Assay Stripwell Plates, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zero-p+implants+packed+with+tricalcium+phosphate+or+locally+removed+bone/bone+mimicking+calcium+phosphate+coated+osteo+assay+stripwell+plates/pm37741978-212-26-33
Average 90 stars, based on 1 article reviews
bone-mimicking calcium phosphate-coated osteo assay stripwell plates - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics octacalcium phosphate (ocp) synthetic bone graft bontree
The surgical procedure. ( A ) A piezoelectric bony window osteotomy, ( B ) the mixture of biomimetic <t>Octacalcium</t> Phosphate <t>(OCP)</t> alloplasts and whole blood, ( C ) the sinus graft, ( D ) the repositioned bony lid, ( E ) the core biopsy harvested using a trephine bur after 6 months of healing, ( F ) the implant fixture placement.
Octacalcium Phosphate (Ocp) Synthetic Bone Graft Bontree, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zero-p+implants+packed+with+tricalcium+phosphate+or+locally+removed+bone/octacalcium+phosphate++ocp++synthetic+bone+graft+bontree/pmc09229888-19-24-23
Average 90 stars, based on 1 article reviews
octacalcium phosphate (ocp) synthetic bone graft bontree - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics phosphates: biomimetic and antibacterial materials for bone implants
The surgical procedure. ( A ) A piezoelectric bony window osteotomy, ( B ) the mixture of biomimetic <t>Octacalcium</t> Phosphate <t>(OCP)</t> alloplasts and whole blood, ( C ) the sinus graft, ( D ) the repositioned bony lid, ( E ) the core biopsy harvested using a trephine bur after 6 months of healing, ( F ) the implant fixture placement.
Phosphates: Biomimetic And Antibacterial Materials For Bone Implants, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zero-p+implants+packed+with+tricalcium+phosphate+or+locally+removed+bone/phosphates++biomimetic+and+antibacterial+materials+for+bone+implants/pm38667262-14-0-1
Average 90 stars, based on 1 article reviews
phosphates: biomimetic and antibacterial materials for bone implants - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Holzel Diagnostika resorbable dicalcium phosphate bone substitutes
The surgical procedure. ( A ) A piezoelectric bony window osteotomy, ( B ) the mixture of biomimetic <t>Octacalcium</t> Phosphate <t>(OCP)</t> alloplasts and whole blood, ( C ) the sinus graft, ( D ) the repositioned bony lid, ( E ) the core biopsy harvested using a trephine bur after 6 months of healing, ( F ) the implant fixture placement.
Resorbable Dicalcium Phosphate Bone Substitutes, supplied by Holzel Diagnostika, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zero-p+implants+packed+with+tricalcium+phosphate+or+locally+removed+bone/resorbable+dicalcium+phosphate+bone+substitutes/us09320828-648-11-2
Average 90 stars, based on 1 article reviews
resorbable dicalcium phosphate bone substitutes - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics calcium phosphate bone substitute
Concentration of agents introduced into the CaP solutions before buffering.
Calcium Phosphate Bone Substitute, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zero-p+implants+packed+with+tricalcium+phosphate+or+locally+removed+bone/calcium+phosphate+bone+substitute/pmc06423068-22-1-0
Average 90 stars, based on 1 article reviews
calcium phosphate bone substitute - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
NovaBone Products calcium phosphate-based bone substitutes
Concentration of agents introduced into the CaP solutions before buffering.
Calcium Phosphate Based Bone Substitutes, supplied by NovaBone Products, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zero-p+implants+packed+with+tricalcium+phosphate+or+locally+removed+bone/calcium+phosphate+based+bone+substitutes/pmc10604717-27-5-7
Average 90 stars, based on 1 article reviews
calcium phosphate-based bone substitutes - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Abyrx Inc tricalcium phosphate bone grafting montage
Concentration of agents introduced into the CaP solutions before buffering.
Tricalcium Phosphate Bone Grafting Montage, supplied by Abyrx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zero-p+implants+packed+with+tricalcium+phosphate+or+locally+removed+bone/tricalcium+phosphate+bone+grafting+montage/pmc11571806-48-11-16
Average 90 stars, based on 1 article reviews
tricalcium phosphate bone grafting montage - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
KU Leuven implantation scaffolds of resorbable calcium-phosphate bone substitutes
Concentration of agents introduced into the CaP solutions before buffering.
Implantation Scaffolds Of Resorbable Calcium Phosphate Bone Substitutes, supplied by KU Leuven, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zero-p+implants+packed+with+tricalcium+phosphate+or+locally+removed+bone/implantation+scaffolds+of+resorbable+calcium+phosphate+bone+substitutes/pm28263862-11-0-43
Average 90 stars, based on 1 article reviews
implantation scaffolds of resorbable calcium-phosphate bone substitutes - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Straumann GmbH implant synthetic bone - 75% hydroxyapatite & 25% β-tricalcium phosphate
Concentration of agents introduced into the CaP solutions before buffering.
Implant Synthetic Bone 75% Hydroxyapatite & 25% β Tricalcium Phosphate, supplied by Straumann GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zero-p+implants+packed+with+tricalcium+phosphate+or+locally+removed+bone/implant+synthetic+bone+++75++hydroxyapatite+++25++%CE%B2+tricalcium+phosphate/pmc09255790-27-14-17
Average 90 stars, based on 1 article reviews
implant synthetic bone - 75% hydroxyapatite & 25% β-tricalcium phosphate - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
DePuy Synthes calcium phosphate bone substitute noriantm
Concentration of agents introduced into the CaP solutions before buffering.
Calcium Phosphate Bone Substitute Noriantm, supplied by DePuy Synthes, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zero-p+implants+packed+with+tricalcium+phosphate+or+locally+removed+bone/calcium+phosphate+bone+substitute+noriantm/pmc05423569-152-1-6
Average 90 stars, based on 1 article reviews
calcium phosphate bone substitute noriantm - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics biomorphic calcium phosphate bone scaffold b. bonetm
Concentration of agents introduced into the CaP solutions before buffering.
Biomorphic Calcium Phosphate Bone Scaffold B. Bonetm, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zero-p+implants+packed+with+tricalcium+phosphate+or+locally+removed+bone/biomorphic+calcium+phosphate+bone+scaffold+b++bonetm/pm39055342-3-14-20
Average 90 stars, based on 1 article reviews
biomorphic calcium phosphate bone scaffold b. bonetm - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Sofamor Danek Group autologous bone and tricalcium phosphate hydroxyapatite mastergraft
Concentration of agents introduced into the CaP solutions before buffering.
Autologous Bone And Tricalcium Phosphate Hydroxyapatite Mastergraft, supplied by Sofamor Danek Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zero-p+implants+packed+with+tricalcium+phosphate+or+locally+removed+bone/autologous+bone+and+tricalcium+phosphate+hydroxyapatite+mastergraft/pm17608332-66-3-10
Average 90 stars, based on 1 article reviews
autologous bone and tricalcium phosphate hydroxyapatite mastergraft - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


The surgical procedure. ( A ) A piezoelectric bony window osteotomy, ( B ) the mixture of biomimetic Octacalcium Phosphate (OCP) alloplasts and whole blood, ( C ) the sinus graft, ( D ) the repositioned bony lid, ( E ) the core biopsy harvested using a trephine bur after 6 months of healing, ( F ) the implant fixture placement.

Journal: Materials

Article Title: Radiographic and Histomorphometric Evaluation of Sinus Floor Augmentation Using Biomimetic Octacalcium Phosphate Alloplasts: A Prospective Pilot Study

doi: 10.3390/ma15124061

Figure Lengend Snippet: The surgical procedure. ( A ) A piezoelectric bony window osteotomy, ( B ) the mixture of biomimetic Octacalcium Phosphate (OCP) alloplasts and whole blood, ( C ) the sinus graft, ( D ) the repositioned bony lid, ( E ) the core biopsy harvested using a trephine bur after 6 months of healing, ( F ) the implant fixture placement.

Article Snippet: This prospective single-arm clinical study aimed to radiographically and histomorphometrically evaluate the efficacy of the lateral approach for sinus floor elevation (LSFE) using biomimetic octacalcium phosphate (OCP) synthetic bone graft (Bontree ® ).

Techniques:

Concentration of agents introduced into the CaP solutions before buffering.

Journal: Frontiers in Pharmacology

Article Title: Osteogenic Enhancement Between Icariin and Bone Morphogenetic Protein 2: A Potential Osteogenic Compound for Bone Tissue Engineering

doi: 10.3389/fphar.2019.00201

Figure Lengend Snippet: Concentration of agents introduced into the CaP solutions before buffering.

Article Snippet: Biomimetic calcium phosphate (BioCaP) bone substitute is a novel drug delivery carrier system.

Techniques: Concentration Assay, In Vitro, In Vivo

Two-dimensional (2D) images of BioCaP and bone by Micro-CT (A) . Bone (red) and BioCaP (white) were separated by the analysis software (B) .

Journal: Frontiers in Pharmacology

Article Title: Osteogenic Enhancement Between Icariin and Bone Morphogenetic Protein 2: A Potential Osteogenic Compound for Bone Tissue Engineering

doi: 10.3389/fphar.2019.00201

Figure Lengend Snippet: Two-dimensional (2D) images of BioCaP and bone by Micro-CT (A) . Bone (red) and BioCaP (white) were separated by the analysis software (B) .

Article Snippet: Biomimetic calcium phosphate (BioCaP) bone substitute is a novel drug delivery carrier system.

Techniques: Micro-CT, Software

The proliferation of MC3T3-E1 cells stimulated by BioCaP alone or BioCaP with Icariin or/and BMP-2. The absorbance was measured on days 1, 4, and 7. Mean values ( n = 3 samples per group) were represented together with the standard deviation. Error bars denote the standard deviation. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗ without lines means versus control (C). C, Control; BioCaP, biomimetic calcium phosphate; I, Icariin; B, BMP-2.

Journal: Frontiers in Pharmacology

Article Title: Osteogenic Enhancement Between Icariin and Bone Morphogenetic Protein 2: A Potential Osteogenic Compound for Bone Tissue Engineering

doi: 10.3389/fphar.2019.00201

Figure Lengend Snippet: The proliferation of MC3T3-E1 cells stimulated by BioCaP alone or BioCaP with Icariin or/and BMP-2. The absorbance was measured on days 1, 4, and 7. Mean values ( n = 3 samples per group) were represented together with the standard deviation. Error bars denote the standard deviation. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗ without lines means versus control (C). C, Control; BioCaP, biomimetic calcium phosphate; I, Icariin; B, BMP-2.

Article Snippet: Biomimetic calcium phosphate (BioCaP) bone substitute is a novel drug delivery carrier system.

Techniques: Standard Deviation, Control

Osteogenic differentiation results of MC3T3-E1 cells after treatment with BioCaP alone or BioCaP with Icariin or/and BMP-2. (A) The ALP activities were determined by colorimetric assay on days 1, 4, and 7. (B) The OCN expressions on days 4, 7, and 10. (C) Macroscopic images of alzarin red stained 3, 4, and 5 weeks after five groups treatment. (D) The mineralization results on 3, 4, and 5 weeks. Mean values ( n = 3 samples per group) were represented together with the standard deviation normalized by total cellular protein. Error bars denote the standard deviation. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗ without lines means versus control (C). C, Control; BioCaP, biomimetic calcium phosphate; I, Icariin; B, BMP-2.

Journal: Frontiers in Pharmacology

Article Title: Osteogenic Enhancement Between Icariin and Bone Morphogenetic Protein 2: A Potential Osteogenic Compound for Bone Tissue Engineering

doi: 10.3389/fphar.2019.00201

Figure Lengend Snippet: Osteogenic differentiation results of MC3T3-E1 cells after treatment with BioCaP alone or BioCaP with Icariin or/and BMP-2. (A) The ALP activities were determined by colorimetric assay on days 1, 4, and 7. (B) The OCN expressions on days 4, 7, and 10. (C) Macroscopic images of alzarin red stained 3, 4, and 5 weeks after five groups treatment. (D) The mineralization results on 3, 4, and 5 weeks. Mean values ( n = 3 samples per group) were represented together with the standard deviation normalized by total cellular protein. Error bars denote the standard deviation. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗ without lines means versus control (C). C, Control; BioCaP, biomimetic calcium phosphate; I, Icariin; B, BMP-2.

Article Snippet: Biomimetic calcium phosphate (BioCaP) bone substitute is a novel drug delivery carrier system.

Techniques: Colorimetric Assay, Staining, Standard Deviation, Control

The time course changes in mRNA expression of (A) ALP, (B) BMP-2 (C) Col1, (D) OCN, (E) Runx2 in MC3T3-E1 on days 1, 4, and 7. Mean values ( n = 3 samples per group) were represented together with the standard deviation. Error bars denote the standard deviation. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗ without lines means versus control (C). C, Control; BioCaP, biomimetic calcium phosphate; I, Icariin; B, BMP-2.

Journal: Frontiers in Pharmacology

Article Title: Osteogenic Enhancement Between Icariin and Bone Morphogenetic Protein 2: A Potential Osteogenic Compound for Bone Tissue Engineering

doi: 10.3389/fphar.2019.00201

Figure Lengend Snippet: The time course changes in mRNA expression of (A) ALP, (B) BMP-2 (C) Col1, (D) OCN, (E) Runx2 in MC3T3-E1 on days 1, 4, and 7. Mean values ( n = 3 samples per group) were represented together with the standard deviation. Error bars denote the standard deviation. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗ without lines means versus control (C). C, Control; BioCaP, biomimetic calcium phosphate; I, Icariin; B, BMP-2.

Article Snippet: Biomimetic calcium phosphate (BioCaP) bone substitute is a novel drug delivery carrier system.

Techniques: Expressing, Standard Deviation, Control

Factor in mRNA expression as a function of the treatment and of the days after treatment.

Journal: Frontiers in Pharmacology

Article Title: Osteogenic Enhancement Between Icariin and Bone Morphogenetic Protein 2: A Potential Osteogenic Compound for Bone Tissue Engineering

doi: 10.3389/fphar.2019.00201

Figure Lengend Snippet: Factor in mRNA expression as a function of the treatment and of the days after treatment.

Article Snippet: Biomimetic calcium phosphate (BioCaP) bone substitute is a novel drug delivery carrier system.

Techniques: Expressing, Control

(A) The Micro-CT images of the bone defects in scalp of the rats 12 weeks after treatment with BioCaP, Icariin-int. BioCaP, BMP-2-int. BioCaP, and Icariin + BMP-2-int. BioCaP. (B) The volume of newly formed bone within the bone defect after 12 weeks postoperation for each group which is analyzed by Micro-CT. Mean value ( n = 6 specimens per group ) are represented together with the standard deviation. ∗∗ P < 0.01. (C) The bone mineral density (mg HA/cm 3 ) of the newly formed bone within the bone defect after 12 weeks postoperation for each group which is analyzed by Micro-CT. Mean value ( n = 6 specimens per group) are represented together with the standard deviation.

Journal: Frontiers in Pharmacology

Article Title: Osteogenic Enhancement Between Icariin and Bone Morphogenetic Protein 2: A Potential Osteogenic Compound for Bone Tissue Engineering

doi: 10.3389/fphar.2019.00201

Figure Lengend Snippet: (A) The Micro-CT images of the bone defects in scalp of the rats 12 weeks after treatment with BioCaP, Icariin-int. BioCaP, BMP-2-int. BioCaP, and Icariin + BMP-2-int. BioCaP. (B) The volume of newly formed bone within the bone defect after 12 weeks postoperation for each group which is analyzed by Micro-CT. Mean value ( n = 6 specimens per group ) are represented together with the standard deviation. ∗∗ P < 0.01. (C) The bone mineral density (mg HA/cm 3 ) of the newly formed bone within the bone defect after 12 weeks postoperation for each group which is analyzed by Micro-CT. Mean value ( n = 6 specimens per group) are represented together with the standard deviation.

Article Snippet: Biomimetic calcium phosphate (BioCaP) bone substitute is a novel drug delivery carrier system.

Techniques: Micro-CT, Standard Deviation

Representative histological micrographs of bone defect of each group at 12 weeks after implantation. The BioCaP granules materials (M) were surround by newly formed bone (B) in Icariin-int. BioCaP, BMP-2-int. BioCaP, and Icariin + BMP-2-int. BioCaP Groups. The slices were surface-stained with McNeal’s Tetrachrome, basic Fuchsine and Toluidine Blue. (A) The panoramic images of the defects of four experiment groups. (B) Scale bar = 200 μm. (C) Scale bar = 100 μm. The vascular (black arrows) was observed in all the groups. (D) The volume of newly formed bone within the bone defect after 12 weeks postoperation for each group which is analyzed by histology. Mean value ( n = 6 specimens per group) are represented together with the standard deviation. ∗∗ P < 0.01

Journal: Frontiers in Pharmacology

Article Title: Osteogenic Enhancement Between Icariin and Bone Morphogenetic Protein 2: A Potential Osteogenic Compound for Bone Tissue Engineering

doi: 10.3389/fphar.2019.00201

Figure Lengend Snippet: Representative histological micrographs of bone defect of each group at 12 weeks after implantation. The BioCaP granules materials (M) were surround by newly formed bone (B) in Icariin-int. BioCaP, BMP-2-int. BioCaP, and Icariin + BMP-2-int. BioCaP Groups. The slices were surface-stained with McNeal’s Tetrachrome, basic Fuchsine and Toluidine Blue. (A) The panoramic images of the defects of four experiment groups. (B) Scale bar = 200 μm. (C) Scale bar = 100 μm. The vascular (black arrows) was observed in all the groups. (D) The volume of newly formed bone within the bone defect after 12 weeks postoperation for each group which is analyzed by histology. Mean value ( n = 6 specimens per group) are represented together with the standard deviation. ∗∗ P < 0.01

Article Snippet: Biomimetic calcium phosphate (BioCaP) bone substitute is a novel drug delivery carrier system.

Techniques: Staining, Standard Deviation